GlassScriptPhysician profile
Lori A Antinozzi
NPI 1306120035
$671.11
in general payments reported to CMS, 2019-2025
17 companies · $230 in 2025
The $230 reported for 2025 was more than what 84% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.20 · 2022: $209 · 2023: $50.58 · 2024: $91.83 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.38 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $154.34 | 2021-2025 | |
| Sage Therapeutics, LLC | $81.77 | 2022-2025 | Zurzuvae |
| Organon LLC | $65.07 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $48.06 | 2024-2025 | Aptima |
| Therapeuticsmd, INC. | $40.48 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.44 | 2022 | |
| Ethicon US, LLC | $35.18 | 2021-2025 | Stratafix |
| Millicent US INC | $29.79 | 2024 | Femring, Intrarosa |
| Astellas Pharma US INC | $24.11 | 2025 | Veozah |
| Coopersurgical, INC. | $22.00 | 2025 | Paragard T 380a |
| Exeltis, USA INC. | $21.99 | 2022 | |
| Myovant Sciences INC. | $20.25 | 2022 | |
| Supernus Pharmaceuticals, INC. | $20.17 | 2025 | Qelbree |
| Mayne Pharma Commercial LLC | $19.68 | 2023 | |
| Molnlycke Health Care US, LLC | $18.59 | 2025 | Biogel Pi Ultratouch, Biogel Pi Micro Indicator Underglove, Biogel Indicator System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $17.26 | 2024 | Ova1 |
| Dysis Medical, INC. | $13.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Antinozzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.